This review aims to integrate mechanistic and clinical evidence, define stage-specific roles of the VitD–VDR axis across the CIN–cancer spectrum, and outline practical strategies and research priorities for VitD-based adjunctive interventions in HPV-associated cervical disease. This evidence concerns the gene VDR and cervicitis.